Loading clinical trials...

NEOnatal Multiexposure to Medical Devices Plasticizers: Endocrine Disruption MIXture Effects and Neurodevelopmental Disorders | Clinical Trials | Clareo Health

NOT_YET_RECRUITING

NEOnatal Multiexposure to Medical Devices Plasticizers: Endocrine Disruption MIXture Effects and Neurodevelopmental Disorders

NCT06726824•University Hospital, Clermont-Ferrand

View on ClinicalTrials.gov

Summary

The goal of this observational study is to evaluate the neurodevelopment of children from the ARMED NEO cohort through the ASQ3 score. Dose the multiexposure to medical devices plasticizers during the neonatal intensive care unit stay increases the risk of developing neurodevelopmental disorders ? Patients (their parents) will complète several questionnaires (ASQ3, environnemental survey, EPICES score) during a planned teleconsultation with the research team

Eligibility

Age

All ages

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Live patient who participated in the ARMED NEO study, included at the Clermont-Ferrand or Lille hospitals
•Patient whose holders of parental authority have expressed their non-opposition to their participation in the study

Exclusion Criteria

•Patient whose guardians have expressed opposition to their participation in the study
•Patient with no French speaking parent
•patient

Locations (2)

CHU Clermont-Ferrand

Clermont-Ferrand, France

CHU de Lille

Lille, France

Key Dates

Start Date

December 1, 2024

Primary Completion Date

June 1, 2025

Completion Date

December 1, 2025

Last Updated

December 10, 2024

Enrollment

ESTIMATED participants

Conditions

Neurodevelopmental Disorder (Diagnosis)

Contacts

Lise Laclautre

CONTACT

0473754963 promo_interne_drci@chu-clermontferrand.fr

Feeding Disorders in Children

NCT07431671

Neurodevelopmental Disorder (Diagnosis)Feeding Disorder+1 more

View study

COMPLETEDNA

Smart Computing Models, Sensors, and Early Diagnostic Speech and Language Deficiencies Indicators in Child Communication

NCT06633874

Developmental Language DisordersDevelopmental Articulation Disorder+2 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 10, 2024Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions